From the Journals

GLP-1 RAs Linked to Higher Hair Loss Risk

A large matched cohort study quantifies the association between glucagon-like peptide-1 receptor agonist use and nonscarring alopecia

Share

  • 1

    GLP-1 RAs are linked to increased odds of nonscarring hair loss.

  • 2

    Study used data from TriNetX US Collaborative Network.

  • 3

    1.62 times odds of androgenetic alopecia at 6 months.

  • 4

    Increased odds for telogen effluvium and overall hair loss by 12 months.

  • 5

    Study conducted from 2014 to

  • 6

    Pediatric data was limited, affecting analysis.

  • 7

    Monitoring of hair loss risk in patients on GLP-1 RAs is necessary.

Original Source(s)

GLP-1 RAs Linked to Higher Hair Loss Risk

A large matched cohort study quantifies the association between glucagon-like peptide-1 receptor agonist use and nonscarring alopecia

  • by Kerri Miller

  • February 19, 2026

  • 3 min

Related Content

Combo Therapy for Psoriasis With Obesity

A phase 3b trial tests ixekizumab plus tirzepatide in adults with moderate-to-severe plaque psoriasis and obesity or overweight.

Apocrine Gland Changes in Early Hidradenitis Suppurativa

Weight Loss Drugs Reshape Facial Surgery: Survey

AAFPRS survey reveals GLP-1 medications drive 50% increase in fat-grafting procedures as patients seek solutions for weight loss-related facial volume loss.